Similar articles

• Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.

  Diabetes Prevention Program Research Group. Diabetes Prevention Program Research Group. Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75. doi: 10.1016/S2213-8587(15)00291-0. Epub 2015 Sep 13. Lancet Diabetes Endocrinol. 2015. PMID: 26377054 Free PMC article. Clinical Trial.
• Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

  Eddy DM, Schlessinger L, Kahn R. Eddy DM, et al. Ann Intern Med. 2005 Aug 16;143(4):251-64. doi: 10.7326/0003-4819-143-4-200508160-00006. Ann Intern Med. 2005. PMID: 16103469
• The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study.

  Herman WH. Herman WH. Clin Diabetes Endocrinol. 2015 Sep 2;1:9. doi: 10.1186/s40842-015-0009-1. eCollection 2015. Clin Diabetes Endocrinol. 2015. PMID: 28702228 Free PMC article.
• Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

  Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group. Aroda VR, et al. Diabetologia. 2017 Sep;60(9):1601-1611. doi: 10.1007/s00125-017-4361-9. Epub 2017 Aug 2. Diabetologia. 2017. PMID: 28770322 Free PMC article. Review.
• Metformin for prevention of type 2 diabetes.

  Hess AM, Sullivan DL. Hess AM, et al. Ann Pharmacother. 2004 Jul-Aug;38(7-8):1283-5. doi: 10.1345/aph.1D537. Epub 2004 May 18. Ann Pharmacother. 2004. PMID: 15150378 Review.